My Cart
You have no items in your shopping cart.
Ship in Europe, Find out rates!
Language
Hirudoid 25000ui*gel 40g
Regular Price
€15.20
Special Price
€13.59
-11%
Save: €1.61
In stock
Recent lowest price:
€13.53
- box Delivery in Italy in 24/48 and free returns
- star3.000+ positive reviews
- dropboxOver 60,000 products in the catalog
Manufacturer
CRINOS
SKU
010386023
Active principle
SULFOPOLIGLICANO
NAME
HIRUDOID 25,000 IU
PHARMACOTHERAPEUTIC CATEGORY
Antivaricose therapy; organic heparinoids.
ACTIVE PRINCIPLES
Glycosaminoglycanopolysulphate (PM 5700-13700) 0.3 g equal to 25000 IU
EXCIPIENTS
Cream: glycerin; potassium hydroxide; stearic acid; lanolin; alcoholcetylstearyl; myristic alcohol; thymol; methyl parahydroxybenzoate; propyl parahydroxybenzoate; isopropyl alcohol; purified water. Gel: isopropanol; polyacrylic acid; propylene glycol; sodium hydroxide; purified water.
INDICATIONS
Superficial thrombophlebitis and phlebitis, inflammation of the varicose veins, hematomas.
CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active substance, to a heparinoid or to any of the excipients.
DOSAGE
Cream: in small inflammatory processes, apply a 3-5 cm long stream of cream 1-2 times a day (about 0.5-1 g) or cover with a gauze compress spread with cream. The cream can be lightly rubbed in the vicinity of the diseased area; do not rub on the inflamed part. In more extensive processes, larger quantities of the drug are required: about 25 cm (about 4 to 6 g) of cream thread per day. Practice the treatment for 3-4 days, after this period halve the dose until the symptoms disappear.Gel: apply a 5-10 cm long drop of gel several times a day. In case of inflamed surfaces it is advisable not to rub on the partemalata but in the immediate vicinity. The gel is particularly suitable for percutaneous therapy of large surfaces. Larger quantities of the drug are then required. Practice the treatment for 3-4 days; after this period, halve the dose until the symptoms disappear.
STORAGE
This medicine does not require any special storage conditions.
WARNINGS
The use, especially if prolonged, of products for cutaneous use can give rise to sensitization phenomena, in which case the treatment must be interrupted. The gel and cream formulations contain an alcohol among the excipients and therefore should not be applied to open gumucous wounds. The cream contains para-hydroxybenzoates, which can cause allergic reactions (including delayed), and lanolin and cetylstearyl alcohol, which can cause local skin reactions (e.g. contact dermatitis). The gel contains propylene glycol which can cause skin irritation.
INTERACTIONS
There are no known interactions with other medicines.
SIDE EFFECTS
There are no known side effects. The reporting of suspected adverse reactions that occur after the authorization of the drug is important, as it allows continuous monitoring of the benefit / risk ratio of the drug. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system.
PREGNANCY AND BREASTFEEDING
There are no special precautions or warnings in case of pregnancy and breastfeeding.
HIRUDOID 25,000 IU
PHARMACOTHERAPEUTIC CATEGORY
Antivaricose therapy; organic heparinoids.
ACTIVE PRINCIPLES
Glycosaminoglycanopolysulphate (PM 5700-13700) 0.3 g equal to 25000 IU
EXCIPIENTS
Cream: glycerin; potassium hydroxide; stearic acid; lanolin; alcoholcetylstearyl; myristic alcohol; thymol; methyl parahydroxybenzoate; propyl parahydroxybenzoate; isopropyl alcohol; purified water. Gel: isopropanol; polyacrylic acid; propylene glycol; sodium hydroxide; purified water.
INDICATIONS
Superficial thrombophlebitis and phlebitis, inflammation of the varicose veins, hematomas.
CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active substance, to a heparinoid or to any of the excipients.
DOSAGE
Cream: in small inflammatory processes, apply a 3-5 cm long stream of cream 1-2 times a day (about 0.5-1 g) or cover with a gauze compress spread with cream. The cream can be lightly rubbed in the vicinity of the diseased area; do not rub on the inflamed part. In more extensive processes, larger quantities of the drug are required: about 25 cm (about 4 to 6 g) of cream thread per day. Practice the treatment for 3-4 days, after this period halve the dose until the symptoms disappear.Gel: apply a 5-10 cm long drop of gel several times a day. In case of inflamed surfaces it is advisable not to rub on the partemalata but in the immediate vicinity. The gel is particularly suitable for percutaneous therapy of large surfaces. Larger quantities of the drug are then required. Practice the treatment for 3-4 days; after this period, halve the dose until the symptoms disappear.
STORAGE
This medicine does not require any special storage conditions.
WARNINGS
The use, especially if prolonged, of products for cutaneous use can give rise to sensitization phenomena, in which case the treatment must be interrupted. The gel and cream formulations contain an alcohol among the excipients and therefore should not be applied to open gumucous wounds. The cream contains para-hydroxybenzoates, which can cause allergic reactions (including delayed), and lanolin and cetylstearyl alcohol, which can cause local skin reactions (e.g. contact dermatitis). The gel contains propylene glycol which can cause skin irritation.
INTERACTIONS
There are no known interactions with other medicines.
SIDE EFFECTS
There are no known side effects. The reporting of suspected adverse reactions that occur after the authorization of the drug is important, as it allows continuous monitoring of the benefit / risk ratio of the drug. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system.
PREGNANCY AND BREASTFEEDING
There are no special precautions or warnings in case of pregnancy and breastfeeding.